Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
NMC Health LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -152.00p -4.96% 2,910.00p 2,916.00p 2,920.00p 3,080.00p 2,898.00p 3,072.00p 463,053 16:35:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1,603.4 210.4 91.0 32.0 6,058.93

NMC Health Share Discussion Threads

Showing 651 to 675 of 675 messages
Chat Pages: 27  26  25  24  23  22  21  20  19  18  17  16  Older
DateSubjectAuthorDiscuss
17/12/2018
13:03
Directors think that by buying shares they can fool the other investors.
smartinvest1
17/12/2018
13:03
Directors think that by buying shares they can fool the other investors.
smartinvest1
15/12/2018
21:38
Last week £760 k purchase of NMC by three directors is a strong positive for the share price, indicating insider confidence that current price levels is a buying opportunity.
1amb
10/12/2018
09:44
Analysts are usually wrong, most have irons in the fire , conflicts of interest so they are biased imo
malcolmmm
06/12/2018
13:52
I am not a shoet seller. I am a story teller. Market can go up and down
smartinvest1
05/12/2018
21:40
mdr26niz. smartinvest might not be totally wrong. The murder could easily lead to further instability in the Middle East. That could impact on Israel and affect investor sentiment about Plus merely because Plus is based in Israel. Whether that is a reason for concern for the stock is another matter.
daijavu
04/12/2018
10:03
at some posts smartinvest looked resonable, untill he wrote that the murder of the journalist in turkey is a reason of concern for this stock... really?
mdr26nlz
04/12/2018
06:00
@ smartinvest1 - of course you are, you are a short seller only wishing for the destruction of this stock, as reflected in all your previous posts.
plexus1
29/11/2018
10:15
Against this -ve background I have bought in
volsung
28/11/2018
09:03
Totally agree with jeferies. The receivable figure in the balance sheet is 500 million usd which is very high. Also the insurance companoes take time to pay some pays after 6 months.
smartinvest1
28/11/2018
08:53
Jefferies has adopted a more cautious approach to blue chip NMC Health, cutting its rating to 'underperform' over a range of concerns, including corporate governance.The bank said that NMC, a healthcare provider based in the United Arab Emirates and listed in London, was "a well-loved story".It continued: "Attractive healthcare fundamentals in the UAE, expansion of the highly profitable IVF segment and close ties to the Saudi government ahead of anticipated privatisation, all translate into double-digit earnings growth on which there is little to no to no tax."But Jefferies had "concerns", including "increasing risks if the company continues on the same path, down which it looks to be accelerating with the recent Aspen and GOSI deals. Hence we believe the market is overestimating the value-creation potential."Other concerns flagged by Jefferies include NMC's expansion into Saudi Arabia, where there is higher reliance on government pay, declining expat population as well as competition from established players.The analysts also highlighted corporate governance concerns with "an increasing focus on EBITDA in both STIP and LTIP and the removal of EPS to be alarming, especially given net income as a percentage of EBITDA has declined from 78% to 53% in 2012-17" and hoped measures will be "addressed by the remuneration committee".Jefferies cut its price target for NMC to 2,940p from 3,411p.
steeplejack
27/11/2018
10:21
amazing how one analyst's comment can knock an share price but it is usually only a short term effect. But in a shaky market with the brexit disaster effect , the drop is even worse than it would have been . It will be a shorters market for quite some time unless we stay in the EU .
arja
27/11/2018
09:44
Jefferies downgrades to UNDERPERFORM with 2940p target. Happy to hold here.
aishah
27/11/2018
09:28
Why the weakness in share price today ?
kikkeridirect
22/11/2018
11:36
UAE healthcare provider NMC Health surged on Wednesday as JPMorgan Cazenove said it continues to be a strong growth story thanks to a mix of organic initiatives and aggressive M&A activity and bumped the stock up to 'overweight' from 'neutral', hiking the price target to 4,265p from 3,450pThe bank noted that NMC has deployed $472m on 14 transactions since the beginning of the year and spent a total of about $2bn on acquisitions over the last three years."Without factoring in any new M&A activity, its medium-term outlook looks impressive with net earnings growing at a three-year compound annual growth rate of 36% between 2017 and 2020 on our numbers," it said.JPM attributed the price target increase to upgraded forecasts and a change to the relative valuation method, as it ow values the healthcare and distribution business separately.It estimated that between its cash balance as of H1 2018, free cash flow generation and additional debt, NMC could deploy another $1bn on M&A activity over the next 18 months."We expect M&A activity to target general healthcare facilities when attractive propositions arise, but also underserved services such as IVF, LT Care, Cosmetic, Paediatric, Oncology, Mental Health, and Rehabilitation."
steeplejack
21/11/2018
16:27
I was right JP Morgan and Merrill Lynch have positive notes out.
alphabeta4
21/11/2018
11:27
Quite possibly, I suspect there could also be a note out somewhere - I know Barclays two days ago wrote about it being one of their top European buys (delayed reaction?). Furthermore, with the tech weakness growth investors are left a little bit stuck of where to park their money - you can't get much more defensive than healthcare.
alphabeta4
21/11/2018
09:06
I presume this leap in price is on the likelihood that Saudi won't be punished by Trump.
steeplejack
05/11/2018
11:03
I belive the managemwnt is only talking about the positive numbers as significant number of the shares of promoters are pledged or strutured.
smartinvest1
26/10/2018
06:28
Its a big gamble to go to saudi market. Anytime sanctions csn happen.Also funding cost is very high difgicult to make money.
smartinvest1
23/10/2018
08:29
Daily Telegraph business insight section today.
blocker2
22/10/2018
13:27
I like the update. We can expect revenue growth approaching 50% and higher profit margin over the next 18 months. Think these forecasts are likely to prove conservative giving them opportunity to surprise on the upside going forward. RM
rampmeister
22/10/2018
10:34
Very wise in view of the international furore surrounding Saudi Arabia.
steeplejack
22/10/2018
09:43
Looks like Prashanth had enough of share price going down, so he thought, let me give it a push ?
startshare
22/10/2018
07:19
sp not been affected by the Saudi scandal.
daijavu
Chat Pages: 27  26  25  24  23  22  21  20  19  18  17  16  Older
Your Recent History
LSE
NMC
NMC Health
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181217 16:51:10